Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BCAX compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
BCAX
Bicara Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
BCAX
Bicara Therapeutics Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
BCAX
Bicara Therapeutics Inc.
Change
7.91
· pre 7.93
· delayed
Mkt cap
$620.2M
Revenue
—
Revenue
—
LLY
ELI Lilly & Co
Change
1,418.01
· pre 1,393.18
· delayed
Pre-market
Nov 3 '26
delayed
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Pre-market
Nov 3 '26
delayed
BCAX
Bicara Therapeutics Inc.
vs
LLY
ELI Lilly & Co
7.91
pre 7.93
delayed
Price
1,418.01
pre 1,393.18
delayed
$620.2M
Mkt cap
$1.3T
—
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
BCAX
7.91
vs
LLY
1,418.01
Pre-market
Nov 3 '26
delayed
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
BCAX, solid
LLY, dashed
Supply-chain overlap
Revenue flow
BCAX: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only BCAX
2
MSD
MSD International GmbH and MSD International Business GmbH
supplier
—
Biocon
unlisted
supplier
Shared
0
No shared counterparties.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
25 more · LLY chain
›